Mesothelioma, a rare and aggressive cancer primarily affecting the lining of the lungs, abdomen, or heart, has historically presented a formidable challenge for oncologists. Traditional treatments like surgery, chemotherapy, and radiation often provide limited benefits, leaving patients with a poor prognosis. However, the emergence of immunotherapy has brought a new wave of hope, offering the…
Mesothelioma New Treatment: 2025 Breakthroughs & Hope Mesothelioma, a rare and aggressive cancer caused primarily by asbestos exposure, has long presented a formidable challenge to the medical community. For decades, treatment options have been limited, often focusing on extending life and managing symptoms rather than offering a cure. However, the landscape of mesothelioma treatment is…
Malignant pleural mesothelioma is a rare and aggressive cancer that primarily affects the lining of the lungs, abdomen, or heart. While treatment options have been limited, the combination of surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) is emerging as a potentially life-extending approach for select patients, particularly those with peritoneal mesothelioma. This innovative technique aims to…